Literature DB >> 18974271

Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis.

Rami I Aqeilan1, John P Hagan, Alain de Bruin, Maysoon Rawahneh, Zaidoun Salah, Eugenio Gaudio, Hasan Siddiqui, Stefano Volinia, Hansjuerg Alder, Jane B Lian, Gary S Stein, Carlo M Croce.   

Abstract

The WW domain-containing oxidoreductase (WWOX) gene encodes a 46-kDa tumor suppressor. The Wwox protein contains two N-terminal WW domains that interact with several transcriptional activators containing proline-tyrosine motifs and a central short-chain dehydrogenase/reductase domain that has been suggested to play a role in steroid metabolism. Recently, we have shown that targeted deletion of the Wwox gene in mice leads to postnatal lethality and defects in bone growth. Here, we report that Wwox-deficient mice display impaired steroidogenesis. Mutant homozygous mice are born with gonadal abnormalities, including failure of Leydig cell development in testis and reduced theca cell proliferation in ovary. Furthermore, Wwox(-/-) mice displayed impaired gene expression of key steroidogenesis enzymes. Affymetrix microarray gene analysis revealed differentially expressed related genes in steroidogenesis in knockout mice testis and ovary as compared with control mice. These results demonstrate the essential requirement for the Wwox tumor suppressor in proper steroidogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974271      PMCID: PMC2654736          DOI: 10.1210/en.2008-1087

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

1.  WW domain-containing oxidoreductase: a candidate tumor suppressor.

Authors:  Nan-Shan Chang; Li-Jin Hsu; Yee-Shin Lin; Feng-Jie Lai; Hamm-Ming Sheu
Journal:  Trends Mol Med       Date:  2006-12-04       Impact factor: 11.951

Review 2.  The development of androgen-independent prostate cancer.

Authors:  B J Feldman; D Feldman
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

3.  Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo.

Authors:  Rami I Aqeilan; John P Hagan; Haifa A Aqeilan; Flavia Pichiorri; Louise Y Y Fong; Carlo M Croce
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

4.  Functional association between Wwox tumor suppressor protein and p73, a p53 homolog.

Authors:  Rami I Aqeilan; Yuri Pekarsky; Juan J Herrero; Alexey Palamarchuk; Jean Letofsky; Teresa Druck; Francesco Trapasso; Shuang-Yin Han; Gerry Melino; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

Review 5.  WWOX in biological control and tumorigenesis.

Authors:  Rami I Aqeilan; Carlo M Croce
Journal:  J Cell Physiol       Date:  2007-08       Impact factor: 6.384

6.  Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer.

Authors:  J E Vivienne Watson; Norman A Doggett; Donna G Albertson; Armann Andaya; Arul Chinnaiyan; Herman van Dekken; David Ginzinger; Christopher Haqq; Karen James; Sherwin Kamkar; David Kowbel; Daniel Pinkel; Lars Schmitt; Jeffry P Simko; Stanislav Volik; Vivian K Weinberg; Pamela L Paris; Colin Collins
Journal:  Oncogene       Date:  2004-04-22       Impact factor: 9.867

7.  Loss of WWOX expression in gastric carcinoma.

Authors:  Rami I Aqeilan; Tamotsu Kuroki; Yuri Pekarsky; Omar Albagha; Francesco Trapasso; Raffaele Baffa; Kay Huebner; Pamela Edmonds; Carlo M Croce
Journal:  Clin Cancer Res       Date:  2004-05-01       Impact factor: 12.531

8.  Targeted deletion of Wwox reveals a tumor suppressor function.

Authors:  Rami I Aqeilan; Francesco Trapasso; Sadiq Hussain; Stefan Costinean; Dean Marshall; Yuri Pekarsky; John P Hagan; Nicola Zanesi; Mohamed Kaou; Gary S Stein; Jane B Lian; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

9.  WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins.

Authors:  John H Ludes-Meyers; Hyunsuk Kil; Andrzej K Bednarek; Jeff Drake; Mark T Bedford; C Marcelo Aldaz
Journal:  Oncogene       Date:  2004-06-24       Impact factor: 9.867

10.  Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.

Authors:  Rami I Aqeilan; Alexey Palamarchuk; Ronald J Weigel; Juan J Herrero; Yuri Pekarsky; Carlo M Croce
Journal:  Cancer Res       Date:  2004-11-15       Impact factor: 12.701

View more
  41 in total

1.  A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development.

Authors:  Stefan White; Jacqueline Hewitt; Erin Turbitt; Yvonne van der Zwan; Remko Hersmus; Stenvert Drop; Peter Koopman; Vincent Harley; Martine Cools; Leendert Looijenga; Andrew Sinclair
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

Review 2.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

3.  GATA4 is a key regulator of steroidogenesis and glycolysis in mouse Leydig cells.

Authors:  Anja Schrade; Antti Kyrönlahti; Oyediran Akinrinade; Marjut Pihlajoki; Merja Häkkinen; Simon Fischer; Tero-Pekka Alastalo; Vidya Velagapudi; Jorma Toppari; David B Wilson; Markku Heikinheimo
Journal:  Endocrinology       Date:  2015-02-10       Impact factor: 4.736

4.  WWOX induces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721.

Authors:  Ben-Shun Hu; Jing-Wang Tan; Guo-Hua Zhu; Dan-Feng Wang; Xian Zhou; Zhi-Qiang Sun
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 5.  Disorders of sex development: new genes, new concepts.

Authors:  Makoto Ono; Vincent R Harley
Journal:  Nat Rev Endocrinol       Date:  2012-12-18       Impact factor: 43.330

6.  WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.

Authors:  Mohammad Abu-Odeh; Zaidoun Salah; Christoph Herbel; Thomas G Hofmann; Rami I Aqeilan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

7.  Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype.

Authors:  Suhaib K Abdeen; Sara Del Mare; Sadeeq Hussain; Muhannad Abu-Remaileh; Zaidoun Salah; John Hagan; Maysoon Rawahneh; Xin-An Pu; Stacey Russell; Janet L Stein; Gary S Stein; Jane B Lian; Rami I Aqeilan
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

Review 8.  WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

Authors:  C Marcelo Aldaz; Brent W Ferguson; Martin C Abba
Journal:  Biochim Biophys Acta       Date:  2014-06-14

9.  Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme.

Authors:  Katarzyna Kosla; Elzbieta Pluciennik; Agata Kurzyk; Dorota Jesionek-Kupnicka; Radzislaw Kordek; Piotr Potemski; Andrzej K Bednarek
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

Review 10.  Translational genetics for diagnosis of human disorders of sex development.

Authors:  Ruth M Baxter; Eric Vilain
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-15       Impact factor: 8.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.